Old Web
English
Sign In
Acemap
>
authorDetail
>
Albiruni R. A. Razak
Albiruni R. A. Razak
Medicine
Pathology
Cancer
Internal medicine
Pharmacodynamics
4
Papers
130
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Determinants of the recommended phase 2 dose of molecular targeted agents
2017
Cancer
Aaron Richard Hansen
Natalie Cook
Eitan Amir
Lillian L. Siu
Albiruni R. A. Razak
Show All
Source
Cite
Save
Citations (5)
Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status.
2015
Cancer
Shao Hui-huang
John Waldron
Michael Milosevic
Xiaowei Shen
Jolie Ringash
Jie Su
L. Tong
Bayardo Perez-Ordoñez
Ilan Weinreb
Andrew Bayley
John Kim
Andrew Hope
B. C. John Cho
Meredith Giuliani
Albiruni R. A. Razak
David Goldstein
W. Shi
Fei-Fei Liu
Wei Xu
Brian O'Sullivan
Show All
Source
Cite
Save
Citations (94)
A first-in-class, first-in-human phase I trial of KPT-330 (selinexor), a selective inhibitor of nuclear export (SINE) in patients (pts) with advanced solid tumors.
2014
Journal of Clinical Oncology
Albiruni R. A. Razak
Morten Mau Soerensen
Amit Mahipal
Sharon Shacham
Cindy Y.F. Yau
Ulrik Lassen
Dilara McCauley
Jennifer Cooksey
David Tan
Jean-Richard Saint-Martin
Yossi Landesman
Gregory R. Pond
Amit M. Oza
Michael Kauffman
Lillian L. Siu
Mansoor Raza Mirza
Show All
Source
Cite
Save
Citations (14)
Tracheobronchial amyloidosis: utilization of radiotherapy as a treatment modality.
2008
The Medscape Journal of Medicine
Poovaneswaran S
Albiruni R. A. Razak
Hilmi Lockman
Pollard K
Mazdai G
Show All
Source
Cite
Save
Citations (17)
1
map